BriaCell Therapeutics Corp. - Common Shares (BCTX) earnings
BCTX earnings moved a median of -3.19% by the close. Quarterly and annual BCTX reports and results, each read against the price at its own news timestamp. Back to the BCTX overview →
12 measured BCTX earnings events.
Where these BCTX earnings landedvs 12 measured BCTX earnings reactions
| Middle 50% of BCTX earnings reactions | -5.08% to +3.44% |
|---|---|
| Median reaction (to close) | -3.19% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 BCTX earnings events with a measured close landed between -5.08% and +3.44%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +1.00% | -4.32% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | +0.52% | +13.61% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | -0.97% | -7.38% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | +0.00% | +3.18% | |
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +2.57% | +0.32% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | +1.98% | -2.82% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | +3.27% | +11.12% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | -3.32% | -7.52% | |
| Form 10-Q BriaCell Therapeutics For: Apr 30 | SEC filing · Form 10-Q | +0.00% | +4.22% | |
| Form 10-Q BriaCell Therapeutics For: Jan 31 | SEC filing · Form 10-Q | -1.78% | -3.56% | |
| Form 10-Q BriaCell Therapeutics For: Oct 31 | SEC filing · Form 10-Q | +0.47% | -3.95% | |
| Form 10-K BriaCell Therapeutics For: Jul 31 | SEC filing · Form 10-K | +0.63% | -9.02% |
Keep exploring
More BCTX: analyst actions → · SEC filings → · BCTX overview →